Anika Therapeutics, Inc.
—- Market cap
- $281.58M
- Debt
- —
- Cash
- −$57.48M
Complete market value, debt and cash evidence is required for enterprise value.
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ANIK · price snapshotP/S 2.50x
$21.04Snapshot Sep 8, 2026, 4:00 PM ET
Implied fair value · at CXW's multiple
$13.2137.2% below market
8.43 ANIK revenue / share×1.57x CXW P/S=$13.21
Market $21.04Implied $13.21
CXW · price snapshotP/S 1.57x
$35.05Snapshot Sep 8, 2026, 4:00 PM ET
Implied fair value · at ANIK's multiple
$55.8059.2% above market
22.36 CXW revenue / share×2.50x ANIK P/S=$55.80
Market $35.05Implied $55.80